Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (47): 8835-8839.doi: 10.3969/j.issn.1673-8225.2010.47.023

Previous Articles     Next Articles

Application of hyaluronic acids for osteoarthritic disease

Li Qi, Tang Xin, Pei Fu-xing, Li Jian   

  1. Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu   610041, Sichuan Province, China
  • Online:2010-11-19 Published:2010-11-19
  • Contact: Li Jian, Professor, Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China hxlijian.china@163.com
  • About author:Li Qi☆, Studying for doctorate, Attending physician, Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China liqimm@163.com

Abstract:

BACKGROUND: Hyaluronic acid, a polymer polysaccharide, has a certain effect on the osteoarthritic diseases and has been widely used. But its mechanism is not entirely clear and the specific effect remains disputes. So how to select appropriate patients, appropriate drugs for getting greater efficacy and reducing side effects has become the aims of many scholars.
OBJECTIVE: To review the application, underlying mechanism, safety, efficacy, indications and adverse reactions of hyaluronic acid used for osteoarthritic diseases.
METHODS: A computer-based online search of CNKI (www.cnki.net) and PubMed database (www.pubmed.com) was performed with key words of “hyaluronic acid, fractures, arthritis” in Chinese and “hyaluronic acid, hyaluronan, osteoarthritis, fracture” in English.
RESULTS AND CONCLUSION: Finally, 47 literatures were included for analysis. Hyaluronic acid is safe and effective for osteoarthritic diseases. The main mechanisms are: coverage, lubrication, cushioning cartilage stress; reducing the intra-articular inflammation; promoting the secretion of endogenous hyaluronic acid. Strict control of its indications and selection of suitable molecular weight hyaluronic acid can increase the symptomatic relief and improve treatment satisfaction, while reducing the medical data waster and adverse events. But some problems such as the course of hyaluronic acid treatment, interval and drug selection are still disputable and require further study.

CLC Number: